Discussing all-things glaucoma and iTrack™ Advance with Dr. James Murphy

Discussing all-things glaucoma and iTrack™ Advance with Dr. James Murphy (USA)
The iTrack™ Advance has been cleared for the indication of fluid infusion and aspiration during surgery, and for catheterization and viscodilation of Schlemm’s canal for the reduction of intraocular pressure (IOP) in adult patients with open-angle glaucoma.
The iTrack™ Advance has a CE Mark (Conformité Européenne) and US Food and Drug Administration (FDA) 510(k) #K221872 for the treatment of open-angle glaucoma.